is semaglutide off the fda shortage list FDA: Novo Nordisk's Ozempic and Wegovy, long in shortage, now available FDA crackdown on off-brand Ozempic

"Monster Energy Has Filed Trademark Complaints Against Pokemon and Monster Hunter Over Use of Word 'Monster'"

Eli Lilly and Company 's Retatrutide Shows Up to 28% Weight Loss in Phase-3 Study Eli Lilly reported promising Phase-3 results for #retatrutide, with the triple agonist therapy demonstrating up to 28% weight loss, marking a major milestone in next-generation obesity treatment innovation

Impact of GLP-1 receptor agonists on idiopathic intracranial hypertension clinical and neurosurgical outcomes: a propensity-matched multi-institutional cohort study

doi: 10.3390/biomedicines14040806 85 GuziorDVQuinnRA

The result would be noticeably different shades of pink